Skip to main content
×
×
Home

Affective instability and the course of bipolar depression: Results from the STEP-BD randomised controlled trial of psychosocial treatment

  • Jonathan P. Stange (a1), Louisa G. Sylvia (a2), Pedro Vieira da Silva Magalhães (a3), David J. Miklowitz (a4), Michael W. Otto (a5), Ellen Frank (a6), Christine Yim (a1), Michael Berk (a7), Darin D. Dougherty (a2), Andrew A. Nierenberg (a2) and Thilo Deckersbach (a2)...
Abstract
Background

Little is known about predictors of recovery from bipolar depression.

Aims

We investigated affective instability (a pattern of frequent and large mood shifts over time) as a predictor of recovery from episodes of bipolar depression and as a moderator of response to psychosocial treatment for acute depression.

Method

A total of 252 out-patients with DSM-IV bipolar I or II disorder and who were depressed enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) and were randomised to one of three types of intensive psychotherapy for depression (n = 141) or a brief psychoeducational intervention (n = 111). All analyses were by intention-to-treat.

Results

Degree of instability of symptoms of depression and mania predicted a lower likelihood of recovery and longer time until recovery, independent of the concurrent effects of symptom severity. Affective instability did not moderate the effects of psychosocial treatment on recovery from depression.

Conclusions

Affective instability may be a clinically relevant characteristic that influences the course of bipolar depression.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Affective instability and the course of bipolar depression: Results from the STEP-BD randomised controlled trial of psychosocial treatment
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Affective instability and the course of bipolar depression: Results from the STEP-BD randomised controlled trial of psychosocial treatment
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Affective instability and the course of bipolar depression: Results from the STEP-BD randomised controlled trial of psychosocial treatment
      Available formats
      ×
Copyright
Corresponding author
Thilo Deckersbach, PhD, Bipolar Clinic and Research Program, Massachusetts General Hospital, Department of Psychiatry, 50 Staniford Street, 5th Floor Boston, MA 02114, USA. Email: tdeckersbach@partners.org
Footnotes
Hide All

STEP-BD was funded in part by contract N01MH80001 from the National Institute of Mental Health (NIMH, Gary Sachs). Support for the development of the psychosocial treatments was provided by grants MH29618 (E.F.), MH43931 (D.J.M.) and MH55101 (D.J.M.) from the NIMH and by the National Alliance for Research on Schizophrenia and Depression (D.J.M.). J.S. was supported by National Research Service Award F31MH099761 from NIMH. L.G.S. received research support from NIMH (grant no. 1K23MH91182-1A1 and N01MH80001-01). D.J.M. has received research support from NIMH (grant no. HR01mh093676 and R33MH097007), Brain and Behavior Research Foundation, American Foundation of Suicide Prevention, Danny Alberts Foundation, Deutsch Foundation, Kayne Foundation, and Attias Family Foundation; M.B. is supported by a NHMRC Senior Principal Research Fellowship (1059660) and has received grant/research support from the NIH (grant no. 1R34MH091384-01A1), Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Rotary Health, Geelong Medical Research Foundation. T.D. was supported in part by a K-23 NIMH Career Award 1K23MH074895-01A2. His research has also been funded by NARSAD, TSA, OCF and Tufts University.

Declaration of interest

L. S. served as a consultant for Bracket Global and Clintara. M.O. has served as a consultant for MicroTransponder Inc. E.F. has served as a consultant for Servier International. M.B. has received research support from Bristol-Myers Squibb (BMS), Eli Lilly, GlaxoSmithKline (GSK), Organon, Novartis, MaynePharma and Servier, has been a speaker for AstraZeneca, BMS, Eli Lilly, GSK, Janssen Cilag, Lundbeck, Merck, Pfizer, SanofiSynthelabo, Servier, Solvay and Wyeth, and served as a consultant to AstraZeneca, BMS, Eli Lilly, GSK, Janssen Cilag, Lundbeck Merck and Servier. A.A.N. has received honoraria or travel expenses from: American Society of Clinical Psychopharmacology, Australasian Society for Bipolar Disorder, Bayamon Region Psychiatric Society, Belvoir Publishing, Boston Center for the Arts, Corcept, Controlled Risk Insurance Company, Dartmouth, Dey Pharma L.P./Mylan Inc, Israel Society for Biological Psychiatry, Johns Hopkins University, National Association of Continuing Education, PAI, Pamlabs, Physicians Postgraduate Press, Ridge Diagnostics, Slack Publishing, Sunovion, Teva Pharmaceuticals, University of Florida, University of Michigan, University of New Mexico, University of Miami, University of Wisconsin, Wolters Klower Publishing. Potential consulting honoraria from AstraZeneca, BMS, Forest, Pfizer, Ridge Diagnostics. Potential support of research at Massachusetts General Hospital (MGH) through Biogen Idec, Dey Pharmaceuticals, Pamlabs, Shire and Sunovian. He owns stock options in Appliance Computing Inc (MindSite.com) and BrainCells Inc. Additional income is possible from Infomedic.com but no revenue has been received to date. Through MGH, A.A.N. is named for copyrights to: the Clinical Positive Affect Scale and the MGH Structured Clinical Interview for the Montgomery–åsberg Depression Scale exclusively licensed to the MGH Clinical Trials Network and Institute (CTNI). T.D. has received honoraria, consultation fees and/or royalties from the MGH Psychiatry Academy, BrainCells Inc, Systems Research and Applications Corporation, Boston University, the Catalan Agency for Health Technology Assessment and Research, the National Association of Social Workers Massachusetts, the Massachusetts Medical Society, Tufts University and National Institute on Drug Abuse. He has also participated in research funded by National Institutes of Health, National Institute on Aging, Agency for Healthcare Research and Quality, Janssen Pharmaceuticals, The Forest Research Institute, Shire Development Inc, Medtronic, Cyberonics and Northstar.

Footnotes
References
Hide All
1 Perlis, RH, Ostacher, MJ, Patel, JK, Marangell, LB, Zhang, H, Wisniewski, SR, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006; 163: 217–24.
2 Angst, F, Stassen, HH, Clayton, PJ, Angst, J. Mortality of patients with mood disorders: follow-up over 34–38 years. J Affect Disord 2002; 68: 167–81.
3 Goldberg, JF, Burdick, KE. Cognitive Dysfunction in Bipolar Disorder. American Psychiatric Publishing, 2008.
4 Goodwin, FK, Jamison, KR. Manic-Depressive Illness (2nd edn). Oxford University Press, 2007.
5 Grant, BF, Stinson, FS, Dawson, DA, Chou, SP, Dufour, MC, Compton, W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004; 61: 807–16.
6 Kessler, RC, Akiskal, HS, Ames, M, Birnbaum, H, Greenberg, P, Hirschfeld, RM, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry 2006; 163: 1561–8.
7 Martínez-Arán, A, Vieta, E, Colom, F, Torrent, C, Sánchez-Moreno, J, Reinares, M, et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord 2004; 6: 224–32.
8 De Dios, C, Ezquiaga, E, Garcia, A, Soler, B, Vieta, E. Time spent with symptoms in a cohort of bipolar disorder outpatients in Spain: a prospective, 18-month follow-up study. J Affect Disord 2010; 125: 7481.
9 Rosa, AR, Reinares, M, Michalak, EE, Bonnin, CM, Sole, B, Franco, C, et al. Functional impairment and disability across mood states in bipolar disorder. Value Health 2010; 13: 984–8.
10 Baldessarini, RJ, Salvatore, P, Khalsa, HM, Gebre-Medhin, P, Imaz, H, González-Pinto, A, et al. Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disord 2010; 12: 264–70.
11 Gitlin, MJ, Swendsen, J, Heller, TL, Hammen, C. Relapse and impairment in bipolar disorder. Am J Psychiatry 1995; 152: 1635–40.
12 Harel, EV, Levkovitz, Y. Effectiveness and safety of adjunctive antidepressants in the treatment of bipolar depression: a review. Isr J Psychiatry Relat Sci 2008; 45: 121–8.
13 Miklowitz, DJ. Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am J Psychiatry 2008; 165: 1408–19.
14 Lauder, SD, Berk, M, Castle, DJ, Dodd, S, Berk, L. The role of psychotherapy in bipolar disorder. Med J Aust 2010; 193: S315.
15 Miklowitz, DJ, Simoneau, TL, George, EL, Richards, JA, Kalbag, A, Sachs-Ericsson, N, et al. Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy. Biol Psychiatry 2000; 48: 582–92.
16 Rea, MM, Tompson, MC, Miklowitz, DJ, Goldstein, MJ, Hwang, S, Mintz, J. Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. J Consult Clin Psychol 2003; 71: 482–92.
17 Cochran, SD. Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. J Consult Clin Psychol 1984; 52: 873–8.
18 Lam, DH, Watkins, ER, Hayward, P, Bright, J, Wright, K, Kerr, N, et al. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry 2003; 60: 145–52.
19 Lam, DH, Hayward, P, Watkins, ER, Wright, K, Sham, P. Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years. Am J Psychiatry 2005; 162: 324–9.
20 Otto, MW, Reilly-Harrington, NA, Kogan, JN, Henin, A, Knauz, RO, Sachs, GS. Managing Bipolar Disorder: A Cognitive-Behavioral Approach (Therapist Guide). Oxford University Press, 2009.
21 Scott, J, Garland, A, Moorhead, S. A pilot study of cognitive therapy in bipolar disorders. Psychol Med 2001; 31: 459–67.
22 Scott, J, Paykel, E, Morriss, R, Bentall, R, Kinderman, P, Johnson, T, et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry 2006; 188: 313–20.
23 Frank, E, Swartz, HA, Kupfer, DJ. Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biol Psychiatry 2000; 48: 593604.
24 Frank, E, Kupfer, DJ, Thase, ME, Mallinger, AG, Swartz, HA, Fagiolini, AM, et al. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry 2005; 62: 9961004.
25 Sachs, GS, Thase, ME, Otto, MW, Bauer, M, Miklowitz, D, Wisniewski, SR, et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 2003; 53: 1028–42.
26 Miklowitz, DJ, Otto, MW, Frank, E, Reilly-Harrington, NA, Wisniewski, SR, Kogan, JN, et al. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry 2007; 64: 419–26.
27 Mitchell, PB, Malhi, GS. Bipolar depression: phenomenological overview and clinical characteristics. Bipolar Disord 2004; 6: 530–9.
28 Sachs, GS, Nierenberg, AA, Calabrese, JR, Marangell, LB, Wisniewski, SR, Gyulai, L, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356: 1711–22.
29 Gitlin, M. Treatment-resistant bipolar disorder. Mol Psychiatry 2006; 11: 227–40.
30 Cole, DP, Thase, ME, Mallinger, AG, Soares, JC, Luther, JF, Kupfer, DJ, et al. Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am J Psychiatry 2002; 159: 116–21.
31 Miklowitz, DJ, Goldstein, MJ, Nuechterlein, KH, Snyder, KS, Mintz, J. Family factors and the course of bipolar affective disorder. Arch Gen Psychiatry 1988; 45: 225–31.
32 Johnson, SL, Winett, CA, Meyer, B, Greenhouse, WJ, Miller, I. Social support and the course of bipolar disorder. J Abnorm Psychol 1999; 108: 558–66.
33 Johnson, SL, Miller, I. Negative life events and time to recovery from episodes of bipolar disorder. J Abnorm Psychol 1997; 106: 449–57.
34 Stange, JP, Sylvia, LG, da Silva Magalhães, PV, Miklowitz, DJ, Otto, MW, Frank, E, et al. Extreme attributions predict the course of bipolar depression: results from the STEP-BD randomized controlled trial of psychosocial treatment. J Clin Psychiatry 2013; 74: 249–55.
35 Strakowski, S. Approaching the challenge of bipolar depression: results from STEP-BD. Am J Psychiatry 2007; 164: 1301–3.
36 Trull, TJ, Solhan, MB, Tragesser, SL, Jahng, S, Wood, PK, Piasecki, TM, et al. Affective instability: measuring a core feature of borderline personality disorder with ecological momentary assessment. J Abnorm Psychol 2008; 117: 647–61.
37 Berenbaum, H, Bredemeier, K, Boden, M, Thompson, RJ, Milanak, M. Affective instability, family history of mood disorders, and neurodevelopmental disturbance. Personal Disord 2011; 2: 220–9.
38 Ebner-Priemer, UW, Eid, M, Kleindienst, N, Stabenow, S, Trull, TJ. Analytic strategies for understanding affective (in) stability and other dynamic processes in psychopathology. J Abnorm Psychol 2009; 118: 195202.
39 McConville, C, Cooper, C. Mood variability and the intensity of depressive states. Cur Psychol 1996; 14: 329–38.
40 Neumann, A, Van Lier, PA, Frijns, T, Meeus, W, Koot, HM. Emotional dynamics in the development of early adolescent psychopathology: a one-year longitudinal study. J Abnorm Child Psychol 2011; 39: 657–69.
41 Thompson, RJ, Mata, J, Jaeggi, SM, Buschkuehl, M, Jonides, J, Gotlib, IH. The everyday emotional experience of adults with major depressive disorder: examining emotional instability, inertia, and reactivity. J Abnorm Psychol 2012; 121: 819–29.
42 Birmaher, B, Goldstein, BI, Axelson, DA, Monk, K, Hickey, MB, Fan, J, et al. Mood lability among offspring of parents with bipolar disorder and community controls. Bipolar Disord 2013; 15: 253–63.
43 Thompson, RJ, Dizen, M, Berenbaum, H. The unique relations between emotional awareness and facets of affective instability. J Res Personality 2009; 43: 875–9.
44 Koval, P, Ogrinz, B, Kuppens, P, Van den Bergh, O, Tuerlinckx, F, Sütterlin, S. Affective instability in daily life is predicted by resting heart rate variability. PloS One 2013; 8: e81536.
45 Schulze, L, Hauenstein, K, Grossmann, A, Schmahl, C, Prehn, K, Fleischer, M, et al. Neuronal correlates of cognitive reappraisal in borderline patients with affective instability. Biol Psychiatry 2011; 69: 564–73.
46 Miller, DJ, Vachon, DD, Lynam, DR. Neuroticism, negative affect, and negative affect instability: establishing convergent and discriminant validity using ecological momentary assessment. Pers Individ Diff 2009; 47: 873–7.
47 Miller, J, Pilkonis, P. Neuroticism and affective instability: the same or different? Am J Psychiatry 2006; 163: 839–45.
48 Nica, EI, Links, PS. Affective instability in borderline personality disorder: experience sampling findings. Curr Psychiatry Rep 2009; 11: 7481.
49 Dunayevich, E, Sax, KW, Keck, PE Jr, McElroy, SL, Sorter, MT, McConville, BJ, et al. Twelve-month outcome in bipolar patients with and without personality disorders. J Clin Psychiatry 2000; 61: 134–9.
50 Zimmerman, M, Chelminski, I, Young, D, Dalrymple, K, Martinez, J. Does the presence of one feature of borderline personality disorder have clinical significance? Implications for dimensional ratings of personality disorders. J Clin Psychiatry 2012; 73: 812.
51 Jahng, S, Wood, PK, Trull, TJ. Analysis of affective instability in ecological momentary assessment: indices using successive difference and group comparison via multilevel modeling. Psychol Meth 2008; 13: 354.
52 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
53 Sachs, GS, Guille, C, McMurrich, SL. A clinical monitoring form for mood disorders. Bipolar Disord 2002; 4: 323–7.
54 First, MB, Spitzer, RL, Gibbon, M, Williams, JBW. Structured Clinical Interview for DSM-IV Axis I Disorders. Biometrics Research Department, New York State Psychiatric Institute, 1995.
55 Sachs, GS. Use of clonazepam for bipolar affective disorder. J Clin Psychiatry 1990; 51: 31–4.
56 Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 2233.
57 Otto, MW, Reilly-Harrington, NA, Knauz, RO, Henin, A, Kogan, JN, Sachs, GS. Managing Bipolar Disorder: A Cognitive Behavior Treatment Program Workbook. Oxford University Press, 2008.
58 Miklowitz, DJ. Bipolar Disorder: A Family-Focused Treatment Approach (2nd edn). Guilford Press, 2010.
59 Otto, MW, Simon, NM, Wisniewski, SR, Miklowitz, DJ, Kogan, JN, Reilly-Harrington, NA, et al. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry 2006; 189: 20–5.
60 McConville, C, Cooper, C. The temporal stability of mood variability. Pers Individ Diff 1997; 23: 161–4.
61 Tabachnik, BG, Fidell, LS. Using Multivariate Statistics (5th edn). Pearson, 2007.
62 Kraemer, HC, Wilson, GT, Fairburn, CG, Agras, WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002; 59: 877–83.
63 George, EL, Miklowitz, DJ, Richards, JA, Simoneau, TL, Taylor, DO. The comorbidity of bipolar disorder and axis II personality disorders: prevalence and clinicalcorrelates. Bipolar Disord 2003; 5: 115–22.
64 Deckersbach, T, Hölzel, BK, Eisner, LR, Stange, JP, Peckham, AD, Dougherty, DD, et al. Mindfulness-based cognitive therapy for nonremitted patients with bipolar disorder. CNS Neurosci Ther 2012; 18: 133–41.
65 Linehan, M. Cognitive-Behavioral Treatment of Borderline Personality Disorder. Guilford Press, 1993.
66 Pe, ML, Raes, F, Kuppens, P. The cognitive building blocks of emotion regulation: ability to update working memory moderates the efficacy of rumination and reappraisal on emotion. PLoS One 2013; 8: 112.
67 Robinson, LJ, Thompson, JM, Gallagher, P, Goswami, U, Young, AH, Ferrier, IN, et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006; 93: 105–15.
68 Liu, RT, Alloy, LB. Stress generation in depression: a systematic review of the empirical literature and recommendations for future study. Clin Psychol Rev 2010; 30: 582–93.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Affective instability and the course of bipolar depression: Results from the STEP-BD randomised controlled trial of psychosocial treatment

  • Jonathan P. Stange (a1), Louisa G. Sylvia (a2), Pedro Vieira da Silva Magalhães (a3), David J. Miklowitz (a4), Michael W. Otto (a5), Ellen Frank (a6), Christine Yim (a1), Michael Berk (a7), Darin D. Dougherty (a2), Andrew A. Nierenberg (a2) and Thilo Deckersbach (a2)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *